Cabaletta Bio (CABA) Net Income (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.77% |
| Sep 30, 2025 | -0.66% |
| Jun 30, 2025 | -25.38% |
| Mar 31, 2025 | -10.30% |
| Dec 31, 2024 | -6.39% |
| Sep 30, 2024 | -10.97% |
| Jun 30, 2024 | -10.20% |
| Mar 31, 2024 | -19.92% |
| Dec 31, 2023 | -26.98% |
| Sep 30, 2023 | -13.54% |
| Jun 30, 2023 | 8.62% |
| Mar 31, 2023 | -1.03% |
| Dec 31, 2022 | -37.32% |
| Sep 30, 2022 | 11.49% |
| Jun 30, 2022 | 0.28% |
| Mar 31, 2022 | 6.78% |
| Dec 31, 2021 | -20.14% |
| Sep 30, 2021 | -3.78% |
| Jun 30, 2021 | -14.81% |
| Mar 31, 2021 | -4.22% |
| Dec 31, 2020 | -10.91% |
| Sep 30, 2020 | -2.96% |
| Jun 30, 2020 | -8.91% |
| Mar 31, 2020 | -38.53% |
| Dec 31, 2019 | -16.19% |
| Sep 30, 2019 | -38.48% |
| Jun 30, 2019 | 4.93% |
| Mar 31, 2019 | -85.41% |
| Dec 31, 2018 | 37.17% |